Circulating tumor cells (CTCs) as a predictor of metastatic disease in patients with biochemical recurrence (BR) of prostate cancer with equivocal scan results.
Jeanny B. Aragon-Ching
No relevant relationships to disclose
Samuel J. Simmens
No relevant relationships to disclose
Steven R. Patierno
No relevant relationships to disclose
Robert S. Siegel
No relevant relationships to disclose